Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Statistics in Medicine|November 26, 2013
A varying-stage adaptive phase II/III clinical trial designGaohong DongPharmaceutical Statistics|June 7, 2016
A modified varying-stage adaptive phase II/III clinical trial designGaohong Dong, Marc VandemeulebroeckeJournal of Biopharmaceutical Statistics|November 28, 2017
The stratified win ratioGaohong Dong, Junshan Qiu, Duolao Wang, et al.Pharmaceutical Statistics|August 4, 2016
A generalized analytic solution to the win ratio to analyze a composite endpoint considering the clinical importance order among componentsGaohong Dong, Di Li, Steffen Ballerstedt, et al.Journal of Biopharmaceutical Statistics|November 7, 2022
Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trialsYing Cui, Gaohong Dong, Pei Fen Kuan, et al.Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University|January 8, 2020
[High expression of DNMT3B promotes proliferation and invasion of hepatocellular carcinoma cells via Hippo signaling pathway]Gaohong Dong, Fuliang Qiu, Changan Liu, et al.Frontiers in Medicine|July 25, 2024
Acne treatment: research progress and new perspectivesYuwei Li, Xinhong Hu, Gaohong Dong, et al.Statistics in Medicine|July 17, 2025
An IPCW Adjusted Win Statistics Approach in Clinical Trials Incorporating Equivalence Margins to Define TiesYing Cui, Bo Huang, Gaohong Dong, et al.Clinical Transplantation|December 31, 2015
Do patient characteristics influence efficacy and renal outcomes in liver transplant patients receiving everolimus?Paolo De Simone, Faouzi Saliba, Gaohong Dong, et al.Statistics in Medicine|March 15, 2012
A Bayesian-frequentist two-stage single-arm phase II clinical trial designGaohong Dong, Weichung Joe Shih, Dirk Moore, et al.Pageof 3